What is the likely cause and appropriate workup and treatment for a patient with an RBC count of 5.46 ×10⁶/µL, low MCH (22.5 pg), low‑normal MCHC (30.6 g/dL), and elevated RDW (15.5 %)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Microcytic Anemia with Elevated RBC Count: Iron Deficiency vs. Thalassemia

This patient has microcytic anemia (low MCH 22.5 pg, low-normal MCHC 30.6 g/dL) with an elevated RBC count (5.46 ×10⁶/µL) and elevated RDW (15.5%), which most likely represents either thalassemia trait or iron deficiency anemia—order a serum ferritin immediately to distinguish between these two conditions.

Interpretation of Laboratory Values

The combination of findings is diagnostically significant:

  • Low MCH (22.5 pg): Indicates microcytosis and hypochromia, characteristic of iron deficiency or thalassemia 1
  • Elevated RBC count (5.46): When combined with microcytosis, this pattern strongly suggests thalassemia trait, though iron deficiency with secondary polycythemia remains possible 2
  • Elevated RDW (15.5%): This is the key discriminating feature—elevated RDW suggests iron deficiency or combined deficiency rather than pure thalassemia, which typically shows normal RDW 1, 3

The elevated RDW is particularly important because it reflects anisocytosis (variation in red cell size), which occurs early in iron deficiency as microcytic cells appear alongside normocytic cells 4. In contrast, thalassemia trait typically produces uniformly small cells with normal RDW 1.

Immediate Diagnostic Workup

Order these tests in the following sequence:

  1. Serum ferritin (most powerful test for iron deficiency):

    • <12 μg/dL = diagnostic of iron deficiency 1
    • 100 μg/dL = iron deficiency almost certainly excluded 1

    • 12-100 μg/dL = may require additional testing if inflammation/malignancy present
  2. If ferritin is low (<12-15 μg/dL): Proceed with GI evaluation (see below)

  3. If ferritin is normal/high: Order hemoglobin electrophoresis to confirm thalassemia trait 1

  4. Consider transferrin saturation if ferritin is equivocal (12-100 μg/dL):

    • <30% supports iron deficiency 1

Critical Clinical Context Needed

Determine the patient's demographic and clinical profile:

  • Sex and menstrual status: If premenopausal woman, menstrual blood loss is the most common cause of iron deficiency 1
  • Ethnicity: Mediterranean, Asian, or African ancestry increases thalassemia likelihood 1
  • GI symptoms: Any history of blood in stool, melena, dyspepsia, or change in bowel habits
  • Medication history: NSAID use is a common cause of occult GI blood loss 1
  • Dietary history: Vegetarian diet, poor intake

If Iron Deficiency is Confirmed

For adult men and postmenopausal women with iron deficiency, gastrointestinal blood loss is the primary concern and requires complete evaluation to exclude malignancy 1:

  1. Upper GI endoscopy with small bowel biopsy (to exclude gastric cancer, celiac disease)
  2. Colonoscopy or barium enema (to exclude colorectal cancer, polyps, angiodysplasia)

This complete evaluation is mandatory even in the absence of overt bleeding, as asymptomatic gastric and colonic carcinoma commonly present with iron deficiency anemia 1.

For premenopausal women: If menstrual history adequately explains blood loss and ferritin is only mildly low, empiric iron therapy with monitoring may be reasonable before invasive testing. However, maintain a low threshold for GI evaluation if response is inadequate.

Common Pitfalls to Avoid

  • Do not assume thalassemia based solely on elevated RBC count—the elevated RDW argues against pure thalassemia and suggests iron deficiency or combined deficiency 1, 3
  • Do not skip ferritin testing—it is the most powerful diagnostic test and guides all subsequent management 1
  • Do not attribute iron deficiency to diet alone in men or postmenopausal women—GI malignancy must be excluded 1
  • Do not rely on MCV alone—combined deficiencies (iron + folate/B12) can normalize MCV while RDW remains elevated 1, 5

Treatment Approach

If iron deficiency is confirmed:

  • Initiate oral iron supplementation (therapeutic trial for 3 weeks can confirm diagnosis) 1
  • Treat underlying cause identified on GI workup
  • Monitor hemoglobin response and repeat ferritin in 3 months

If thalassemia trait is confirmed:

  • No iron supplementation needed (unless concurrent iron deficiency documented)
  • Genetic counseling if reproductive age
  • No further workup required for stable trait

Related Questions

What does an elevated red blood cell (RBC) count with low mean corpuscular hemoglobin (MCH), low mean corpuscular hemoglobin concentration (MCHC), and high red cell distribution width (RDW) indicate?
In a patient with type 2 diabetes mellitus who has low serum creatinine, low mean corpuscular hemoglobin (MCH) and low mean corpuscular volume (MCV) indicating microcytic hypochromic anemia, elevated red cell distribution width (RDW), and a high red blood cell (RBC) count, what are the possible causes and what should be the next diagnostic step?
Is a 57-year-old male with a red blood cell count of 4.67 ×10⁶/µL, hemoglobin of 15.5 g/dL, and hematocrit of 43.9% at risk for anemia?
What is the most likely diagnosis and appropriate evaluation and management for a 40‑year‑old woman with hemoglobin 8 g/dL, hematocrit 29.2 %, microcytic anemia (MCV 68.9 fL, MCH 18.9 pg, MCHC 27.4 g/dL), elevated RDW 17.4 % and thrombocytosis (platelet count 479 ×10⁹/L)?
What is the likely diagnosis for a patient with elevated red blood cell count, low mean corpuscular volume, and normal hemoglobin?
What are the treatment options for a 77-year-old man with Gleason 6 (3+3) prostate adenocarcinoma involving 4 of 14 cores and focal high‑grade prostatic intra‑epithelial neoplasia (PIN) present in 3 of 12 cores?
What is the potassium deficit for a 70‑kg adult with a serum potassium of 3.29 mEq/L?
What is the appropriate oral (by mouth) dosing regimen for methylene blue, including indications, contraindications, and monitoring?
What is the estimated total-body potassium deficit and appropriate replacement regimen for a 50‑kg adult with a serum potassium of 3.29 mEq/L?
In a 77-year-old man with a prior prostate biopsy revealing Gleason score 6 prostate cancer in 2 of 12 cores, does this finding change the management plan?
Which angiotensin‑II receptor blocker (ARB) is recommended for a patient with reduced renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.